When did Molecular Data's stock split?

Molecular Data's stock reverse split before market open on Monday, May 23rd 2022. The 1-15 reverse split was announced on Monday, May 23rd 2022. The number of shares owned by shareholders was adjusted after the closing bell on Monday, May 23rd 2022. An investor that had 100 shares of stock prior to the reverse split would have 7 shares after the split.

When did Molecular Data IPO?

Molecular Data (MKD) raised $69 million in an IPO on the week of December 30th 2019. The company issued 11,500,000 shares at a price of $5.00-$7.00 per share. AMTD, Fosun Hani and Boustead Securities served as the underwriters for the IPO and Tiger Brokers and Guotai Junan International were co-managers.

NASDAQ:MKD

Molecular Data (MKD) Stock Price, News & Analysis

→ Did You Get Your Free Bitcoin Yet? (From Crypto Swap Profits) (Ad)

Free MKD Stock Alerts

Notice: This company has been marked as potentially delisted and may not be actively trading.

Compare

Today's Range: N/A
50-Day Range: $0.40
▼
$0.71
52-Week Range: N/A

Volume: N/A
Average Volume: N/A
Market Capitalization: N/A

P/E Ratio: N/A
Dividend Yield: N/A
Price Target: N/A

Stock Analysis

Get Molecular Data alerts:

Ad Crypto Swap Profits

Did You Get Your Free Bitcoin Yet?

And my special guest is willing to give you $10 in Bitcoin (BTC) if you take it seriously. Right now is a very important time to pay attention to what we are doing and what is happening. If you wait... it will be too late. This week we are holding several workshops and if you attend and pay attention my special guest is going to send you $10 in Bitcoin.

>> Register right here

About Molecular Data Stock (NASDAQ:MKD)

Molecular Data Inc., through its subsidiaries, operates in the chemical e-commerce business in the People's Republic of China. The company operates technology-driven platform that connects participants along the chemical value chain through its integrated solutions. It delivers e-commerce solutions, financial solutions, warehousing and logistics solutions, and software-as-a-service suites for participants in the traditional chemical industry. The company offers its e-commerce solutions through online platform that consists of molbase.com and molbase.cn websites; Moku Data Weixin account; Chemical Community app; and other ancillary platforms. Molecular Data Inc. was founded in 2013 and is headquartered in Shanghai, the People's Republic of China.

Ad Crypto Swap Profits

Did You Get Your Free Bitcoin Yet?

>> Register right here

MKD Stock News Headlines

April 15, 2024 | msn.com

Developing a machine learning model to explore DNA methylation

April 12, 2024 | marketwatch.com

Molecular Templates to Cut 30% of Staff, Chief Medical Officer

April 16, 2024 | Paradigm Press (Ad)

AI “wealth window” is closing soon!

Today, I’m making my boldest prediction ever. Next-generation AI technology will create the first $100 TRILLION industry.

April 12, 2024 | msn.com

Researchers shed light on the molecular causes of different functions of opioid receptors

April 11, 2024 | msn.com

SciY launches new BioDrive tool and registration module for enhanced data management and collaboration in molecular biology research

March 29, 2024 | msn.com

Advancing drug discovery with AI: Introducing the KEDD framework

March 29, 2024 | msn.com

Gene editing technology reveals molecular mechanisms governing diatom population density signals

March 27, 2024 | msn.com

Advancements in Molecular Memory Unlocking the Potential of Photoswitch Molecules

April 16, 2024 | Paradigm Press (Ad)

AI “wealth window” is closing soon!

Today, I’m making my boldest prediction ever. Next-generation AI technology will create the first $100 TRILLION industry.

March 16, 2024 | markets.businessinsider.com

Molecular Partners AG: Strong Financials & Promising Pipeline Justify Buy Rating

March 14, 2024 | msn.com

Study identifies molecular alterations in brain tissue and blood of people who committed suicide

February 21, 2024 | msn.com

New findings on the link between myotonic dystrophy 2 and autoimmune diseases

February 6, 2024 | msn.com

Study identifies molecular mechanisms of rare neurodevelopmental disorder

February 1, 2024 | msn.com

Human cells building 'molecular highways' captured for first time

January 23, 2024 | msn.com

4D Molecular gets FDA rare pediatric disease status for CF drug

January 14, 2024 | msn.com

New research provides a molecular look at the mechanisms behind pigmentation variation

January 9, 2024 | msn.com

Research better characterizes a rare form of leukemia on the molecular level

January 2, 2024 | msn.com

Previously unidentified protein variant shields against Parkinson's disease

November 13, 2023 | tmcnet.com

BostonGene to Showcase AI-Driven Molecular Profiling Solutions at the Association for Molecular Pathology 2023 Annual Meeting

October 10, 2023 | markets.businessinsider.com

CENTOGENE Expands Multiomic Diagnostic Portfolio With Newly-Launched Transcriptomic Offering

August 15, 2023 | msn.com

Molecular communication: Experts are interpreting the language of life

August 9, 2023 | lse.co.uk

Molecular Enrgy Share Chat

July 28, 2023 | investing.com

Molecular Data Inc (MKDTY)

July 7, 2023 | msn.com

4D Molecular Therapeutics: A Complicated Story

June 19, 2023 | benzinga.com

Molecular Diagnostics Partnering Deals Report 2016-2023 - Undertake Due Diligence to Assess Suitability of Your Proposed Deal Terms

June 7, 2023 | seekingalpha.com

4D Molecular stock rallies following promising data for CF therapy

May 17, 2023 | marketwatch.com

Molecular Biology Enzymes, Reagents And Kits Market Future Statistics and Probability by 2030

See More Headlines

Receive MKD Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Molecular Data and its competitors with MarketBeat's FREE daily newsletter.

Company Calendar

Today: 4/16/2024
Fiscal Year End: 12/31/2024

Get Stock Alerts

Industry, Sector and Symbol

Stock Exchange: NASDAQ
Sector: Business Services
Industry: Business services, not elsewhere classified
Sub-Industry: N/A
Current Symbol: NASDAQ:MKD
CUSIP: N/A
CIK: 1758736
Web: www.molbase.cn
Phone: 86-21-5436-5166
Fax: 86-40-0602-1666
Employees: 189
Year Founded: N/A

Profitability

EPS (Most Recent Fiscal Year): N/A
Trailing P/E Ratio: N/A
Forward P/E Ratio: N/A
P/E Growth: N/A
Net Income: N/A
Net Margins: N/A
Pretax Margin: N/A
Return on Equity: N/A
Return on Assets: N/A

Debt

Debt-to-Equity Ratio: N/A
Current Ratio: N/A
Quick Ratio: N/A

Sales & Book Value

Annual Sales: N/A
Price / Sales: N/A
Cash Flow: N/A
Price / Cash Flow: N/A
Book Value: N/A
Price / Book: N/A

Miscellaneous

Outstanding Shares: N/A
Free Float: N/A
Market Cap: N/A
Optionable: Not Optionable
Beta: N/A

10 "Recession Proof" Stocks That Will Thrive in Any Market

Which stocks are likely to thrive in today's challenging market? Click the link below and we'll send you MarketBeat's list of ten stocks that will drive in any economic environment.

Get This Free Report

Key Executives

Mr. Steven Foo (Age 50)
CEO & CFO
Dr. Dongliang Chang (Age 47)
Founder & Chairman of Board of Directors
Mr. Jingming Zhong
Compliance Officer

Key Competitors

View All Competitors

MKD Stock Analysis - Frequently Asked Questions

When did Molecular Data's stock split?: Molecular Data's stock reverse split before market open on Monday, May 23rd 2022. The 1-15 reverse split was announced on Monday, May 23rd 2022. The number of shares owned by shareholders was adjusted after the closing bell on Monday, May 23rd 2022. An investor that had 100 shares of stock prior to the reverse split would have 7 shares after the split.
When did Molecular Data IPO?: Molecular Data (MKD) raised $69 million in an IPO on the week of December 30th 2019. The company issued 11,500,000 shares at a price of $5.00-$7.00 per share. AMTD, Fosun Hani and Boustead Securities served as the underwriters for the IPO and Tiger Brokers and Guotai Junan International were co-managers.

This page (NASDAQ:MKD) was last updated on 4/16/2024 by MarketBeat.com Staff

From Our Partners

Get 30 Days of MarketBeat All Access Free

Best-in-Class Portfolio Monitoring
View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio.
Stock Ideas and Recommendations
Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report.
Advanced Stock Screeners and Research Tools
Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis.

Start Your 30-Day Free Trial

Molecular Data (MKD) Stock Price, News & Analysis

About Molecular Data Stock (NASDAQ:MKD)

MKD Stock News Headlines

Company Calendar

Industry, Sector and Symbol

Profitability

Debt

Sales & Book Value

Miscellaneous

Key Executives

Key Competitors

MKD Stock Analysis - Frequently Asked Questions

About MarketBeat

MarketBeat Products

Popular Tools

Financial Calendars

Terms & Info